{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:38:07Z","timestamp":1792528687394,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014547","name":"Parker Institute for Cancer Immunotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trecan.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:36:26Z","timestamp":1792438586000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MAIT cells in gastrointestinal cancer: immunity to therapy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9858-300X","authenticated-orcid":false,"given":"Yan-Ruide","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.09.009_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.trecan.2026.09.009_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2026.09.009_bb0015","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/ijerph20043640","article-title":"The rise of gastrointestinal cancers as a global phenomenon: unhealthy behavior or progress?","volume":"20","author":"Jardim","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.trecan.2026.09.009_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-025-02335-3","article-title":"Microbiota in cancer: current understandings and future perspectives","volume":"11","author":"Yao","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.09.009_bb0025","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1053\/j.gastro.2014.01.001","article-title":"Gastrointestinal malignancy and the microbiome","volume":"146","author":"Abreu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2026.09.009_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13027-024-00605-3","article-title":"Gastrointestinal cancer resistance to treatment: the role of microbiota","volume":"19","author":"Sadeghi","year":"2024","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature01433","article-title":"Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1","volume":"422","author":"Treiner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.09.009_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2015.12.005","article-title":"Diversity of T cells restricted by the MHC class I-related molecule MR1 facilitates differential antigen recognition","volume":"44","author":"Gherardin","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2026.09.009_bb0045","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature11605","article-title":"MR1 presents microbial vitamin B metabolites to MAIT cells","volume":"491","author":"Kjer-Nielsen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.09.009_bb0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature13160","article-title":"T-cell activation by transitory neo-antigens derived from distinct microbial pathways","volume":"509","author":"Corbett","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.09.009_bb0060","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20250711","article-title":"The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites","volume":"223","author":"Abdelaal","year":"2026","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2026.09.009_bb0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1126\/science.aaw2719","article-title":"Microbial metabolites control the thymic development of mucosal-associated invariant T cells","volume":"366","author":"Legoux","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.09.009_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade6924","article-title":"Sulfated bile acid is a host-derived ligand for MAIT cells","volume":"9","author":"Ito","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s42003-024-05912-4","article-title":"Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation","volume":"7","author":"Kulicke","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41590-020-0616-6","article-title":"The molecular basis underpinning the potency and specificity of MAIT cell antigens","volume":"21","author":"Awad","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ni.3565","article-title":"A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage","volume":"17","author":"Koay","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0090","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41385-018-0072-x","article-title":"Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation","volume":"11","author":"Tastan","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127588","article-title":"MAIT cells and the microbiome","volume":"14","author":"Jabeen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584521","article-title":"MAIT cells in barrier tissues: lessons from immediate neighbors","volume":"11","author":"Amini","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0105","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/biomedicines12091946","article-title":"Circulating gut microbe-derived metabolites are associated with hepatocellular carcinoma","volume":"12","author":"Banerjee","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.trecan.2026.09.009_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn2362","article-title":"MAIT cell heterogeneity across paired human tissues reveals specialization of distinct regulatory and enhanced effector profiles","volume":"9","author":"Kammann","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/mi.2015.69","article-title":"CD161intCD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut","volume":"9","author":"Fergusson","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ymthe.2022.11.019","article-title":"Mucosal-associated invariant T cells for cancer immunotherapy","volume":"31","author":"Li","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.trecan.2026.09.009_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12929-025-01125-x","article-title":"Biological functions and therapeutic applications of human mucosal-associated invariant T cells","volume":"32","author":"Fang","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.trecan.2026.09.009_bb0130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.tim.2025.03.011","article-title":"The microbiota shapes the life trajectory of mucosal-associated invariant T cells","volume":"33","author":"Li","year":"2025","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0135","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2326-6066.CIR-20-0925","article-title":"Activating mucosal-associated invariant T cells induces a broad antitumor response","volume":"9","author":"Ruf","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2026.09.009_bb0140","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.2100856","article-title":"Engineering human MAIT cells with chimeric antigen receptors for cancer immunotherapy","volume":"209","author":"Dogan","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2020.12.002","article-title":"The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease","volume":"69","author":"Crowther","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mi.2014.81","article-title":"MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets","volume":"8","author":"Kurioka","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/2159-8290.CD-19-0569","article-title":"MAIT cells promote tumor initiation, growth, and metastases via tumor MR1","volume":"10","author":"Yan","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.09.009_bb0160","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00262-015-1764-7","article-title":"Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients","volume":"64","author":"Zabijak","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trecan.2026.09.009_bb0165","article-title":"Human tumor-infiltrating MAIT cells display hallmarks of bacterial antigen recognition in colorectal cancer","volume":"1","author":"Li","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.trecan.2026.09.009_bb0170","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.cell.2023.07.026","article-title":"Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin","volume":"186","author":"Ruf","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.09.009_bb0175","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1158\/1078-0432.CCR-18-3040","article-title":"Activated and exhausted MAIT cells foster disease progression and indicate poor outcome in hepatocellular carcinoma","volume":"25","author":"Duan","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2026.09.009_bb0180","doi-asserted-by":"crossref","DOI":"10.2147\/JHC.S575861","article-title":"Integrative single-cell and spatial transcriptomic analysis reveals MAIT cell dysfunction in relapsed HCC","volume":"13","author":"Park","year":"2026","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.trecan.2026.09.009_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003685","article-title":"Activated but impaired IFN-\u03b3 production of mucosal-associated invariant T cells in patients with hepatocellular carcinoma","volume":"9","author":"Huang","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0190","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.32222","article-title":"Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma","volume":"75","author":"Zimmer","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.trecan.2026.09.009_bb0195","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1500258","article-title":"Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-\u03b3","volume":"195","author":"Sundstr\u00f6m","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13391","article-title":"Mucosal-associated invariant T cells modulate innate immune cells and inhibit colon cancer growth","volume":"100","author":"Cheng","year":"2024","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0205","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.2147\/OTT.S332822","article-title":"The study of mucosal-associated invariant T cells in colon cancer and roles in immune activities","volume":"14","author":"Mo","year":"2021","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.trecan.2026.09.009_bb0210","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1007\/s00262-021-02939-y","article-title":"Exhaustion in tumor-infiltrating mucosal-associated invariant T (MAIT) cells from colon cancer patients","volume":"70","author":"Rodin","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trecan.2026.09.009_bb0215","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00262-017-2050-7","article-title":"Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment","volume":"66","author":"Shaler","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trecan.2026.09.009_bb0220","doi-asserted-by":"crossref","first-page":"76274","DOI":"10.18632\/oncotarget.11187","article-title":"Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer","volume":"7","author":"Won","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.trecan.2026.09.009_bb0225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13578-020-00518-9","article-title":"Decrease of peripheral blood mucosal-associated invariant T cells and impaired serum Granzyme-B production in patients with gastric cancer","volume":"11","author":"Shao","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.trecan.2026.09.009_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008694","article-title":"Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer","volume":"12","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0235","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2019.01580","article-title":"Mucosal-associated invariant T cells display diminished effector capacity in oesophageal adenocarcinoma","volume":"10","author":"Melo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-06991-9","article-title":"Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver","volume":"626","author":"Fan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.09.009_bb0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41698-020-0123-0","article-title":"Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells","volume":"4","author":"Court","year":"2020","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0255","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12967-023-04575-9","article-title":"Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.trecan.2026.09.009_bb0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-024-00998-8","article-title":"Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies","volume":"31","author":"Li","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.trecan.2026.09.009_bb0265","series-title":"Hepato-Pancreato-Biliary Malignancies: Diagnosis and Treatment in the 21st Century","first-page":"1","article-title":"Cholangiocarcinoma: epidemiology, pathogenesis, and prognosis","author":"Namn","year":"2021"},{"key":"10.1016\/j.trecan.2026.09.009_bb0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/diagnostics13020233","article-title":"Diagnosis of cholangiocarcinoma","volume":"13","author":"Shin","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.trecan.2026.09.009_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.51","article-title":"MAIT cells: new guardians of the liver","volume":"5","author":"Kurioka","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0280","article-title":"Target tumor microenvironment by innate T cells","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103807","article-title":"Interaction between gut microbiota and T cell immunity in colorectal cancer","volume":"24","author":"Jing","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.trecan.2026.09.009_bb0290","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s12013-025-01683-9","article-title":"The gut microbiome and colorectal cancer: an integrative review of the underlying mechanisms","volume":"83","author":"Karam","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.trecan.2026.09.009_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-337343","article-title":"MAIT cell enrichment in Lynch syndrome is associated with immune surveillance and colorectal cancer risk","author":"Yang","year":"2026","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2026.09.009_bb0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13099-025-00729-w","article-title":"Gut microbiome and gastric cancer: microbial interactions and therapeutic potential","volume":"17","author":"Elghannam","year":"2025","journal-title":"Gut Pathog."},{"key":"10.1016\/j.trecan.2026.09.009_bb0305","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/microorganisms11051312","article-title":"Helicobacter pylori and its role in gastric cancer","volume":"11","author":"Reyes","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.trecan.2026.09.009_bb0310","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.09.009_bb0315","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer \u2013 clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0320","article-title":"Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer","volume":"6","author":"Aznar","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.trecan.2026.09.009_bb0325","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2517786122","article-title":"Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell-engineered mesothelin-redirected CAR-NKT cells","volume":"122","author":"Li","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.09.009_bb0330","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143888","article-title":"Immune determinants of Barrett\u2019s progression to esophageal adenocarcinoma","volume":"6","author":"Lagisetty","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.trecan.2026.09.009_bb0335","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41416-021-01331-y","article-title":"The tumour immune microenvironment in oesophageal cancer","volume":"125","author":"Davern","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0340","article-title":"Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy","volume":"10","author":"Chen","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.trecan.2026.09.009_bb0345","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkag073","article-title":"Lactate conditioning reprograms mucosal-associated invariant T cell metabolism boosting effector function","volume":"215","author":"Berisha","year":"2026","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0350","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00262-018-2132-1","article-title":"Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?","volume":"67","author":"Haeryfar","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trecan.2026.09.009_bb0355","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/cancers13071582","article-title":"Mucosal associated invariant T cells in cancer-friend or foe?","volume":"13","author":"O\u2019Neill","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.009_bb0360","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.treopn.2026.05.004","article-title":"Rewriting CAR-T fate through cytokine engineering","volume":"1","author":"Li","year":"2026","journal-title":"Trends Open"},{"key":"10.1016\/j.trecan.2026.09.009_bb0365","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41385-021-00425-3","article-title":"Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primates","volume":"14","author":"Sakai","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1594712","article-title":"Control of MAIT cell functions by cytokines in health and disease","volume":"16","author":"Camard","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0375","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1186\/s12967-025-07259-8","article-title":"Innovative gene engineering strategies to address tumor antigen escape in cell therapy","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.trecan.2026.09.009_bb0380","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.trecan.2025.03.001","article-title":"The clinical landscape of CAR-engineered unconventional T cells","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0385","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.molmed.2025.05.014","article-title":"IL-15 in CAR engineering: striking an efficacy-safety balance","volume":"31","author":"Li","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.trecan.2026.09.009_bb0390","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.trecan.2025.06.008","article-title":"IL-18 revives dysfunctional CAR-T cells","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0395","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41577-023-00934-1","article-title":"MR1 antigen presentation to MAIT cells and other MR1-restricted T cells","volume":"24","author":"McWilliam","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0400","doi-asserted-by":"crossref","DOI":"10.4110\/in.2026.26.e8","article-title":"Dual roles of MAIT cells in the tumor microenvironment: implications for cancer immunity and therapy","volume":"26","author":"Choi","year":"2026","journal-title":"Immune Netw."},{"key":"10.1016\/j.trecan.2026.09.009_bb0405","article-title":"Acetoacetate suppresses colon cancer via an MR1-MAIT axis","author":"Clay","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2026.09.009_bb0410","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2011-05-353789","article-title":"Human MAIT and CD8\u03b1\u03b1 cells develop from a pool of type-17 precommitted CD8+ T cells","volume":"119","author":"Walker","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.09.009_bb0415","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/mi.2016.30","article-title":"MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation","volume":"10","author":"Gibbs","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"17","author":"Nakamura","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1369236","article-title":"Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential","volume":"15","author":"Yigit","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0430","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2414230122","article-title":"Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieu","volume":"122","author":"Boulouis","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.09.009_bb0435","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012496","article-title":"MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment","volume":"13","author":"Habaz","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0440","article-title":"Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axis","volume":"7","author":"Keretsu","year":"2025","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.trecan.2026.09.009_bb0445","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41590-019-0465-3","article-title":"Molecular mechanisms of lineage decisions in metabolite-specific T cells","volume":"20","author":"Legoux","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0450","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2020.01014","article-title":"MAIT cell activation and functions","volume":"11","author":"Hinks","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0455","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.3390\/ijms24044084","article-title":"Graft-versus-host disease modulation by innate T cells","volume":"24","author":"Fang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2026.09.009_bb0460","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.3390\/cells10123497","article-title":"Development of stem cell-derived immune cells for off-the-shelf cancer immunotherapies","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.trecan.2026.09.009_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585134","article-title":"Interleukin (IL)-12 and IL-18 synergize to promote MAIT cell IL-17A and IL-17F production independently of IL-23 signaling","volume":"11","author":"Cole","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0470","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1158\/1538-7445.AM2026-4316","article-title":"Abstract 4316: an in vivo MAIT cell activation and rejuvenation system for liver cancer therapy","volume":"86","author":"Li","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.09.009_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1367","article-title":"Circulating CD8+ mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients","volume":"11","author":"Vorwald","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005902","article-title":"Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy","volume":"11","author":"Shi","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2026.09.009_bb0485","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2312631","article-title":"Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer","volume":"13","author":"Sundstr\u00f6m","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trecan.2026.09.009_bb0490","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.3390\/biomedicines10123160","article-title":"Harnessing the power of mucosal-associated invariant T (MAIT) cells in cancer cell therapy","volume":"10","author":"Sugimoto","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.trecan.2026.09.009_bb0495","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf177","article-title":"Immune checkpoint expression in mucosal-associated invariant T cells is stimulus-dependent","volume":"118","author":"Clutter","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0500","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4049\/immunohorizons.1900061","article-title":"Inflammatory cytokines induce sustained CTLA-4 cell surface expression on human MAIT cells","volume":"4","author":"Berkson","year":"2020","journal-title":"Immunohorizons"},{"key":"10.1016\/j.trecan.2026.09.009_bb0505","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/cancers13061440","article-title":"CTLA-4 in regulatory T cells for cancer immunotherapy","volume":"13","author":"Sobhani","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2026.09.009_bb0510","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.09.009_bb0515","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2026.09.009_bb0520","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-026-02602-x","article-title":"Spatiotemporal profiling reveals distinct dynamics and checkpoint regulations of CAR-T and CAR-NKT cells against solid tumors","volume":"11","author":"Li","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.09.009_bb0525","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrclinonc.2016.168","article-title":"PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas","volume":"14","author":"Goodman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0530","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/v11030272","article-title":"Tissue-resident innate and innate-like lymphocyte responses to viral infection","volume":"11","author":"Hildreth","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.trecan.2026.09.009_bb0535","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41385-021-00391-w","article-title":"MAIT cells, guardians of skin and mucosa?","volume":"14","author":"Nel","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0540","series-title":"Handbook of Cancer and Immunology","first-page":"1","article-title":"The role of innate T cells in cancer","author":"Chen","year":"2022"},{"key":"10.1016\/j.trecan.2026.09.009_bb0545","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molimm.2020.12.007","article-title":"Mouse models illuminate MAIT cell biology","volume":"130","author":"Wang","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0550","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.4049\/jimmunol.1403224","article-title":"In vitro and in vivo analysis of the Gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells","volume":"194","author":"Soudais","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2026.09.009_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8531","article-title":"Transcriptomes and metabolism define mouse and human MAIT cell populations","volume":"8","author":"Chandra","year":"2023","journal-title":"Sci. Immunol."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326002207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326002207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:39:10Z","timestamp":1792525150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326002207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":111,"alternative-id":["S2405803326002207"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.09.009","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAIT cells in gastrointestinal cancer: immunity to therapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}